HomeLRMR • NASDAQ
add
Larimar Therapeutics Inc
Previous close
$7.35
Day range
$7.18 - $7.63
Year range
$2.18 - $13.68
Market cap
484.20M USD
Avg Volume
389.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.16M | 35.66% |
Net income | -12.99M | -37.86% |
Net profit margin | — | — |
Earnings per share | -0.29 | -38.10% |
EBITDA | -14.08M | -35.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 86.79M | -26.71% |
Total assets | 95.94M | -24.11% |
Total liabilities | 14.22M | -8.30% |
Total equity | 81.72M | — |
Shares outstanding | 63.80M | — |
Price to book | 3.95 | — |
Return on assets | -35.42% | — |
Return on capital | -38.20% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -12.99M | -37.86% |
Cash from operations | -9.34M | -40.03% |
Cash from investing | -2.63M | 94.97% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -11.97M | 79.78% |
Free cash flow | -4.69M | -38.81% |
About
Founded
2005
Headquarters
Website
Employees
42